BSN 315 HESI
PHARMACOLOGY V1 EXAM
Nightingale College
Actual Qs & Verified Ans to Pass the Exam
This Hesi test contains:
❖ passing score Guarantee
❖ Format Set of Multiple-choice
❖ questions with incorporating Next
Generation NCLEX (NGN) and Case scenarios
questions
❖ Expert-Verified Explanations & Solutions
,1. The healthcare provider prescribes propylthiouracil (PTU) and
Lugol's solution, a strong iodine solution, for a client with
hyperthyroidism. How should the nurse schedule the administration
of these medications?
Answer Choices:
A. Give parenteral dose once every 24 hours.
B. Offer both drugs together with a meal.
C. Schedule both medications at bedtime.
D. Administer iodine one hour before PTU.
Correct Answer: B
Expert Rationale:
Both PTU and Lugol's iodine solution should be taken with meals to
decrease gastrointestinal upset and optimize absorption. There is no
clinical advantage to staggering their administration by one hour.
2. A client is receiving orlistat as part of a weight management
program. Which ongoing assessment should be included in the plan of
care to determine the effectiveness of the medication?
Answer Choices:
A. Depression screening.
B. Body mass index (BMI).
C. Daily calorie count.
D. Serum protein levels.
,Correct Answer: B
Expert Rationale:
Orlistat works by inhibiting fat absorption, leading to weight loss.
Monitoring BMI allows objective evaluation of the drug’s effectiveness in
weight management. Depression screening, calorie count, and serum
protein levels are supportive but not direct measures of orlistat
effectiveness.
3. A client with generalized anxiety disorder (GAD) receives a new
prescription for lorazepam. Which statement provided by the client
requires additional instruction by the nurse?
Answer Choices:
A. Use relaxation techniques to reduce excessive anxiety.
B. Move slowly from a sitting position to a standing position.
C. Avoid alcohol and other sedatives while taking the medication.
D. Stop taking the medication if intended effect is not immediate.
Correct Answer: D
Expert Rationale:
Lorazepam may take time to achieve full therapeutic effect; abrupt
discontinuation or premature cessation can cause withdrawal and symptom
relapse. Clients must be advised to adhere to the prescribed regimen and
communicate concerns to the provider.
, 4. The nurse is administering sodium polystyrene sulfonate to a client
in acute kidney injury (AKI). Which laboratory finding indicates that
the medication has been effective?
Reference Range:
Glucose [74 to 106 mg/dL (4.1 to 5.9 mmol/L)]
Hemoglobin [14 to 18 g/dL (140 to 180 g/L)]
Potassium [3.5 to 5 mEq/L (3.5 to 5 mmol/L)]
Ammonia [10 to 80 µg/dL (6 to 47 µmol/L)]
Answer Choices:
A. Serum ammonia level of 30 µg/dL (17.62 µmol/dL)
B. Serum glucose level of 120 mg/dL (6.7 mmol/L)
C. Serum potassium level of 3.8 mEq/L (3.8 mmol/L)
D. Hemoglobin level of 13.5 g/dL (135 g/L)
Correct Answer: C
Expert Rationale:
Sodium polystyrene sulfonate (Kayexalate) is used in hyperkalemia to
reduce serum potassium by exchanging sodium ions for potassium in the
intestines. An effective dose will lower potassium into the normal range
(3.5–5 mEq/L). The other parameters are not direct indicators of sodium
polystyrene sulfonate effectiveness. Hyperglycemia and ammonia levels
relate to other organ systems or conditions.
PHARMACOLOGY V1 EXAM
Nightingale College
Actual Qs & Verified Ans to Pass the Exam
This Hesi test contains:
❖ passing score Guarantee
❖ Format Set of Multiple-choice
❖ questions with incorporating Next
Generation NCLEX (NGN) and Case scenarios
questions
❖ Expert-Verified Explanations & Solutions
,1. The healthcare provider prescribes propylthiouracil (PTU) and
Lugol's solution, a strong iodine solution, for a client with
hyperthyroidism. How should the nurse schedule the administration
of these medications?
Answer Choices:
A. Give parenteral dose once every 24 hours.
B. Offer both drugs together with a meal.
C. Schedule both medications at bedtime.
D. Administer iodine one hour before PTU.
Correct Answer: B
Expert Rationale:
Both PTU and Lugol's iodine solution should be taken with meals to
decrease gastrointestinal upset and optimize absorption. There is no
clinical advantage to staggering their administration by one hour.
2. A client is receiving orlistat as part of a weight management
program. Which ongoing assessment should be included in the plan of
care to determine the effectiveness of the medication?
Answer Choices:
A. Depression screening.
B. Body mass index (BMI).
C. Daily calorie count.
D. Serum protein levels.
,Correct Answer: B
Expert Rationale:
Orlistat works by inhibiting fat absorption, leading to weight loss.
Monitoring BMI allows objective evaluation of the drug’s effectiveness in
weight management. Depression screening, calorie count, and serum
protein levels are supportive but not direct measures of orlistat
effectiveness.
3. A client with generalized anxiety disorder (GAD) receives a new
prescription for lorazepam. Which statement provided by the client
requires additional instruction by the nurse?
Answer Choices:
A. Use relaxation techniques to reduce excessive anxiety.
B. Move slowly from a sitting position to a standing position.
C. Avoid alcohol and other sedatives while taking the medication.
D. Stop taking the medication if intended effect is not immediate.
Correct Answer: D
Expert Rationale:
Lorazepam may take time to achieve full therapeutic effect; abrupt
discontinuation or premature cessation can cause withdrawal and symptom
relapse. Clients must be advised to adhere to the prescribed regimen and
communicate concerns to the provider.
, 4. The nurse is administering sodium polystyrene sulfonate to a client
in acute kidney injury (AKI). Which laboratory finding indicates that
the medication has been effective?
Reference Range:
Glucose [74 to 106 mg/dL (4.1 to 5.9 mmol/L)]
Hemoglobin [14 to 18 g/dL (140 to 180 g/L)]
Potassium [3.5 to 5 mEq/L (3.5 to 5 mmol/L)]
Ammonia [10 to 80 µg/dL (6 to 47 µmol/L)]
Answer Choices:
A. Serum ammonia level of 30 µg/dL (17.62 µmol/dL)
B. Serum glucose level of 120 mg/dL (6.7 mmol/L)
C. Serum potassium level of 3.8 mEq/L (3.8 mmol/L)
D. Hemoglobin level of 13.5 g/dL (135 g/L)
Correct Answer: C
Expert Rationale:
Sodium polystyrene sulfonate (Kayexalate) is used in hyperkalemia to
reduce serum potassium by exchanging sodium ions for potassium in the
intestines. An effective dose will lower potassium into the normal range
(3.5–5 mEq/L). The other parameters are not direct indicators of sodium
polystyrene sulfonate effectiveness. Hyperglycemia and ammonia levels
relate to other organ systems or conditions.
